Share
- Release Date: 27/12/12 15:07
- Summary: NTA: MLN: MLN NAV $0.8293 as at 25/12/12
- Price Sensitive: No
- Download Document 1.43KB
MLN
27/12/2012 13:07
NTA
REL: 1307 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8293 as at 25/12/12
MLN NAV $0.8293 as at 25/12/12
Date 25/12/2012 18/12/2012
MLN NAV $0.8293 $0.8122
Share price close $0.67 $0.66
Discount 19% 19%
The above NAV is unaudited.
The NAV per share is after deducting treasury stock (shares acquired under
the Marlin Global buyback programme).
The five largest portfolio holdings at 25 December 2012 are approximately as
follows:
Biotest (Germany) 6%
Stratec Biomedical (Germany) 5%
Sarin Technologies (Israel) 5%
Orthofix International (US) 4%
Wasion (China) 4%
BACKGROUND
Marlin Global Limited is a listed investment company that invests in
companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00231658 For:MLN Type:NTA Time:2012-12-27 13:07:19
